Macular degeneration is one of the leading causes of blindness in people over the age of 60 and a trans-Atlantic study may have found the culprit behind this problem. Researchers from the University of Southampton in the UK and the University of Iowa in the USA believe the Serping 1 gene is responsible for age-related macular degeneration (AMD). This discovery is expected to help scientists find better treatments and improve screening processes for patients. The finding was recently published in the on-line version of The Lancet.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze